The Scientific Advisory Board is a group of expert researchers and clinicians from the UK and Europe. They oversee and advise on Target Ovarian Cancer's research programme.
The Board provides advice on:
- development of the research strategy and funding programme
- which project proposals should be invited to make a full application
- external reviewers for grant applications
- external peer reviewer and research champion comments on full grant applications
- make recommendations for research funding to our Board of Trustees
- annual review of funded projects.
The Scientific Advisory Board must comply with, and declare conflicts of interest in line with, our conflicts of interest policy.
Board members
Chair: Professor Fiona Thistlethwaite, Medical Director of The Christie Clinical Research Facility
Professor Chris Lord, Deputy Head of Division and Leader of the Gene Function Team at The Institute of Cancer Research, London
Professor Sadaf Ghaem-Maghami, Professor of Gynaecological Oncology, Department of Surgery & Cancer - Faculty of Medicine, Imperial College London
Sadie Jones, Consultant Gynaecology Oncology Surgeon and Clinical Research Fellow, Cardiff University
Dr Rowan Miller, consultant medical oncologist, University College London and St Bartholomew's Hospitals.
